Metreleptin subcutaneous injection 11.25mg “Kiezi” (YJ code: 2499414D1031, standard: 11.25mg x 1 bottle), manufactured by Kieji Pharma Japan, contains metreleptin (genetical recombination). This recombinant leptin analog is used as replacement therapy for complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
Metreleptin subcutaneous injection 11.25mg “Kiezi”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →